Genentech and Roche May Be Close to Deal
Roche raised their bid for the biotech last Friday to $93 dollars per share, luring Genentech back to
the negotiating table.
No related posts.
Related posts brought to you by Yet Another Related Posts Plugin.
Categories: Top Pharmaceutical companies
